ImpediMed Limited
IPDQF
$0.01
$0.00-17.65%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.99% | -7.60% | -16.70% | -14.51% | -14.68% |
| Total Depreciation and Amortization | -3.75% | -6.69% | -173.04% | -167.92% | 89.59% |
| Total Amortization of Deferred Charges | -- | -- | 132.16% | 127.81% | -- |
| Total Other Non-Cash Items | 43.14% | 38.77% | 117.08% | 116.76% | -34.38% |
| Change in Net Operating Assets | -- | -- | 171.18% | 166.17% | -- |
| Cash from Operations | -10.34% | -6.97% | 34.96% | 36.18% | -14.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 86.13% | 86.48% | 77.06% | 77.50% | 94.02% |
| Cash from Investing | 86.13% | 86.48% | 73.00% | 73.51% | 94.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 22.07% | 22.07% | 16.67% | 16.67% | 6.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,847.03% | 2,761.02% | 5,713.91% | 5,611.41% | 7.90% |
| Foreign Exchange rate Adjustments | -175.56% | -173.27% | -476.30% | -469.01% | 1,072.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.57% | 53.06% | 135.56% | 134.90% | 21.20% |